The Global Cold Pain Therapy Market is experiencing steady and significant growth, driven by a surge in sports injuries, orthopedic surgeries, and an aging global population. According to a research report published by The Insight Partners, the market was valued at approximately US$ 2.19 billion in 2021 and is projected to reach US$ 3.14 billion by 2028, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2022 to 2028.

Cold pain therapy — also known as cryotherapy — involves the application of cold materials or devices to manage pain, reduce swelling, and limit inflammation in orthopedic conditions, soft tissue injuries, and musculoskeletal disorders. By reducing blood flow to an affected area, cold therapy offers an effective, non-pharmacological approach to pain management, making it increasingly popular in both clinical and home settings.

Get PDF Sample: https://www.theinsightpartners.com/sample/TIPHE100001328

What's Driving the Growth?

One of the primary drivers of the cold pain therapy market is the rising incidence of sports-related injuries. With more people embracing active lifestyles through gym workouts, recreational sports, and competitive athletics, injuries such as ligament tears, rotator cuff damage, tendon ruptures, and sprains have become increasingly common. Reports from Hopkins Medicine indicate that approximately 3.5 million sports-related injuries are recorded in the United States annually, placing significant demand on effective pain management solutions.

Alongside sports injuries, the growing geriatric population is contributing substantially to market expansion. Older adults are disproportionately affected by musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, and osteoporosis — all of which often require surgical intervention and post-operative pain management. According to the World Health Organization, musculoskeletal diseases affect around 1.71 billion people globally, with low back pain emerging as the leading cause of disability across 160 countries.

Additionally, road accidents and trauma cases contribute to orthopedic surgeries, further fueling demand. The rise in total knee and hip replacement procedures — projected to grow by 673% by 2030 in the US alone — reinforces the need for reliable post-surgical pain management, including cold therapy.

Market Segmentation at a Glance

The cold pain therapy market is segmented across three key dimensions: application, offering, and end user.

By application, surgery recovery holds the largest market share. Cold compression therapy machines have become a cornerstone of post-operative rehabilitation for hip and knee replacements, outperforming traditional ice packs in terms of effectiveness and patient comfort.

Other major application segments include runner's knee, tendonitis, sprains and sports injuries, arthritis pain, lower back pain, and pain management under casts or splints.

In terms of offering, the over-the-counter (OTC) segment dominates, reflecting strong consumer preference for accessible, self-administered pain relief products. Ice wraps, cold packs, compression therapy systems, and rehabilitation exercise programs form the broader product landscape.

On the end-user front, hospitals lead the market, followed by clinics, rehabilitation centers, ambulatory surgical centers, and individual consumers. The growing adoption of home-use cold therapy devices is also opening new revenue streams in the individual segment.

Regional Insights

North America leads the global market due to its high volume of orthopedic procedures, advanced healthcare infrastructure, and strong product availability. Asia-Pacific is emerging as a lucrative growth region, particularly China, where a rapidly aging population is driving orthopedic healthcare demand. Australia is also witnessing notable growth, supported by high rates of knee and hip replacement surgeries and active market players expanding distribution networks.

Key Players Shaping the Market

The competitive landscape includes companies such as DJO Global, Breg Inc., Brownmed Inc., Cardinal Health, Ossur hf, ThermoTek Inc., and Vive Health LLC. These players are focused on product innovation, strategic partnerships, and geographic expansion to meet evolving patient and clinical needs.

Looking Ahead

With a strong pipeline of innovative products and rising global demand for non-invasive pain management, the cold pain therapy market is well-positioned for sustained growth through 2028 and beyond.